Hans-Martin Schneble und Roche - Info zur Person

(1 - 7 von 7

)

2022 Annual Meeting | P16 - Poster Session 16

www.aan.com

— Hans-Martin Schneble, MD, Dr. Schneble has received personal compensation for serving as an employee of F. Hoffmann-La Roche Ltd.. › Details

LinkedIn: Hans-Martin Schneble – Senior Medical Director Ocrelizumab ...ch.linkedin.com › hans-martin-schneble-b

Hans-Martin Schneble. Senior Medical Director in the Ocrelizumab-Associate Group department. Clinical Science Leader. RocheResidency in Neurology.

LinkedIn: Hans-Martin Schneble, MD, MBA - Linkedinch.linkedin.com › hans-martin-schneble-md-mba-b0...

Hans-Martin Schneble, MD, MBA. Global Development Leader Ocrelizumab at Roche. RocheResidency in Neurology. Metropolregion Basel500+ Kontakte.

CTAD Alzheimer

www.ctad-alzheimer.com

Luc Bracoud, MSc1, Hans-Martin Schneble, MD2, Raluca Gramada, MD3, Fabrice Bonneville, MD, PhD3, Florent Roche, MSc1,. › files › files

Sustained Reduction in 48-Week Confirmed Disability ...

medically.gene.com

von JS Wolinsky · · Zitiert von: 2 — Hans-Martin Schneble is an employee and a shareholder of. F. Hoffmann-La Roche Ltd. James Overell is currently an employee and shareholder of. › dam › ectrims-2021

2022 Annual Meeting of the CMSC

www.medcommshydhosting.com

— Hans-Martin Schneble: F. Hoffmann-La Roche Ltd (employee, shareholder). Ben Townsend: F. Hoffmann-La Roche Ltd (ownership interest, salary). › Abstracts

2022 Annual Meeting of the CMSC - Allen Press

meridian.allenpress.com

— Hans-Martin Schneble: F. Hoffmann-La Roche Ltd (employee, shareholder). Ben Townsend: F. Hoffmann-La Roche Ltd (ownership interest, salary). › ijmsc › article-pdf

Verwandte Suchanfragen zu Hans-Martin Schneble

Robert Glanzman
Hans-Peter Hartung
Qing Wang

Ulrich Sure
Hansjörg Schneble
Hans Schneble

Personen
Vorname "Hans-Martin" (1354)
Name "Schneble" (107)

sortiert nach Relevanz / Datum

Erweiterte Suche

Person-Suchen: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z